mTOR Inhibition Leads to Src-Mediated EGFR Internalisation and Degradation in Glioma Cells
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
mTOR Inhibition Leads to Src-Mediated EGFR Internalisation and Degradation in Glioma Cells
Authors
Keywords
-
Journal
Cancers
Volume 12, Issue 8, Pages 2266
Publisher
MDPI AG
Online
2020-08-13
DOI
10.3390/cancers12082266
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- EMT Regulation by Autophagy: A New Perspective in Glioblastoma Biology
- (2019) Barbara Colella et al. Cancers
- Properties of FDA-approved small molecule protein kinase inhibitors: A 2020 update
- (2019) Robert Roskoski PHARMACOLOGICAL RESEARCH
- LC3C-Mediated Autophagy Selectively Regulates the Met RTK and HGF-Stimulated Migration and Invasion
- (2019) Emily S. Bell et al. Cell Reports
- Current and emerging EGFR therapies for glioblastoma
- (2018) Stefan Alexandru Artene et al. JOURNAL OF IMMUNOASSAY & IMMUNOCHEMISTRY
- A brief history of autophagy from cell biology to physiology and disease
- (2018) Noboru Mizushima NATURE CELL BIOLOGY
- Epidermal growth factor receptor and EGFRvIII in glioblastoma: signaling pathways and targeted therapies
- (2018) Zhenyi An et al. ONCOGENE
- Receptor Tyrosine Kinase Ubiquitination and De-Ubiquitination in Signal Transduction and Receptor Trafficking
- (2018) William Critchley et al. Cells
- Autophagy induction impairs Wnt/β-catenin signalling through β-catenin relocalisation in glioblastoma cells
- (2018) Barbara Colella et al. CELLULAR SIGNALLING
- Interplay of autophagy, receptor tyrosine kinase signalling and endocytic trafficking
- (2017) Jane Fraser et al. Essays in Biochemistry
- mTOR complex 1 activity is required to maintain the canonical endocytic recycling pathway against lysosomal delivery
- (2017) Kristin Dauner et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The EGFR odyssey – from activation to destruction in space and time
- (2017) Jeroen Bakker et al. JOURNAL OF CELL SCIENCE
- Emerging functions of the EGFR in cancer
- (2017) Sara Sigismund et al. Molecular Oncology
- Reticulon 3–dependent ER-PM contact sites control EGFR nonclathrin endocytosis
- (2017) Giusi Caldieri et al. SCIENCE
- Epidermal growth factor receptor in glioblastoma
- (2017) Hongsheng Xu et al. Oncology Letters
- A phase I dose-escalation study of XL147 (SAR245408), a PI3K inhibitor administered orally to patients (pts) with advanced malignancies.
- (2017) G. Edelman et al. JOURNAL OF CLINICAL ONCOLOGY
- Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)
- (2016) Daniel J Klionsky et al. Autophagy
- Proteasome inhibitors induce FLT3-ITD degradation through autophagy in AML cells
- (2015) C. Larrue et al. BLOOD
- A Kinase-Independent Role for EGF Receptor in Autophagy Initiation
- (2015) Xiaojun Tan et al. CELL
- The effect of the size of fluorescent dextran on its endocytic pathway
- (2015) Lei Li et al. CELL BIOLOGY INTERNATIONAL
- Autophagy induction impairs migration and invasion by reversing EMT in glioblastoma cells
- (2015) Myriam Catalano et al. Molecular Oncology
- mTOR inhibition activates overall protein degradation by the ubiquitin proteasome system as well as by autophagy
- (2015) Jinghui Zhao et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The EGFR Family: Not So Prototypical Receptor Tyrosine Kinases
- (2014) M. A. Lemmon et al. Cold Spring Harbor Perspectives in Biology
- The ErbB/HER family of protein-tyrosine kinases and cancer
- (2013) Robert Roskoski PHARMACOLOGICAL RESEARCH
- PI3K regulates MEK/ERK signaling in breast cancer via the Rac-GEF, P-Rex1
- (2013) H. Ebi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- EGF receptor trafficking: consequences for signaling and cancer
- (2013) Alejandra Tomas et al. TRENDS IN CELL BIOLOGY
- Endocytosis of Receptor Tyrosine Kinases
- (2013) L. K. Goh et al. Cold Spring Harbor Perspectives in Biology
- Oncogenic Mutations Counteract Intrinsic Disorder in the EGFR Kinase and Promote Receptor Dimerization
- (2012) Yibing Shan et al. CELL
- EGFR ligands exhibit functional differences in models of paracrine and autocrine signaling
- (2012) Kristy J. Wilson et al. GROWTH FACTORS
- Src family kinases mediate epidermal growth factor receptor signaling from lipid rafts in breast cancer cells
- (2011) Mary E. Irwin et al. CANCER BIOLOGY & THERAPY
- Inhibition of PI3K/mTOR pathways in glioblastoma and implications for combination therapy with temozolomide
- (2011) G. Prasad et al. NEURO-ONCOLOGY
- Nuclear trafficking of the epidermal growth factor receptor family membrane proteins
- (2010) Y-N Wang et al. ONCOGENE
- mTORC1-Mediated Cell Proliferation, But Not Cell Growth, Controlled by the 4E-BPs
- (2010) R. J. O. Dowling et al. SCIENCE
- Epidermal Growth Factor Receptor Translocation to the Mitochondria
- (2009) Michelle L. Demory et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- An ATP-competitive Mammalian Target of Rapamycin Inhibitor Reveals Rapamycin-resistant Functions of mTORC1
- (2009) Carson C. Thoreen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Endocytosis and signalling: intertwining molecular networks
- (2009) Alexander Sorkin et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Oncogenic EGFR Signaling Networks in Glioma
- (2009) P. H. Huang et al. Science Signaling
- c-Src trafficking and co-localization with the EGF receptor promotes EGF ligand-independent EGF receptor activation and signaling
- (2008) Mrudula Donepudi et al. CELLULAR SIGNALLING
- Endocytic downregulation of ErbB receptors: mechanisms and relevance in cancer
- (2008) Kirstine Roepstorff et al. HISTOCHEMISTRY AND CELL BIOLOGY
- Functional selectivity of EGF family peptide growth factors: Implications for cancer
- (2008) Kristy J. Wilson et al. PHARMACOLOGY & THERAPEUTICS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started